Search Results
Dr. Goy Discusses Single-Agent Ibrutinib in MCL
Dr. Goy Discusses Ibrutinib With Venetoclax in MCL
Dr. Goy Discusses Long-Term Follow-Up Results for Ibrutinib in MCL
Dr. Wang Discusses Single-Agent Acalabrutinib in MCL
Dr. Goy on Efficacy With Ibrutinib in MCL
Dr. Goy on Acalabrutinib Versus Ibrutinib in MCL
Goy Predicts Strategies for the Future of MCL Treatment
Dr. Wang on Updated Data With Single-Agent Acalabrutinib in MCL
Dr. Goy Discusses Challenges in Treatment of MCL
Dr. Goy on Promising Data With Acalabrutinib in MCL
Dr. Goy Discusses BTK Inhibitors in MCL
New Agents for Mantle Cell Lymphoma